All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated LoansInvestment Grade Loans

AstraZeneca taps three banks to bridge fund $39bn Alexion buy


AstraZeneca, the UK pharmaceuticals company, has lined up $17.5bn of bridge loans from three banks to back its $39bn acquisition of US biotech firm Alexion.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login